Despite these limitations, our study identifies a potentially important prognostic role of PROX1 in resectable non-small cell lung cancer, and provides a foundation for future prospective investigations incorporating molecular profiling, standardized follow-up, and multicenter validation. This evidence concerns the gene PROX1 and non-small cell lung carcinoma.